Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: Rocket Pharmaceuticals Insider Extends 90-Day Selling Trend

05/13/2021 | 07:52pm EDT


ę MT Newswires 2021
All news about ROCKET PHARMACEUTICALS, INC.
06/22ROCKET PHARMACEUTICALS : Significant Insider Selling Continues at Rocket Pharmac..
MT
06/22ROCKET PHARMACEUTICALS : Insider at Rocket Pharmaceuticals (RCKT) Makes Signific..
MT
06/21INSIDER TRENDS : Rocket Pharmaceuticals Insider Continues 90-Day Selling Trend
MT
06/21ROCKET PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holde..
AQ
05/14ROCKET PHARMACEUTICALS : Significant Insider Selling Reported in Shares of Rocke..
MT
05/13INSIDER TRENDS : Rocket Pharmaceuticals Insider Extends 90-Day Selling Trend
MT
05/13ROCKET PHARMACEUTICALS : Presents Positive Clinical Data from Fanconi Anemia, Le..
BU
05/13Rocket Pharmaceuticals, Inc. Presents Positive Clinical Data from Fanconi Ane..
CI
05/12ROCKET PHARMACEUTICALS : —Updated Low Dose Results in RP-A501 Treatment fo..
PU
05/11SECTOR UPDATE : Health Care Stocks Ending Tuesday Session Lower, But Biotech Sha..
MT
More news
Financials (USD)
Sales 2021 10,0 M - -
Net income 2021 -162 M - -
Net cash 2021 282 M - -
P/E ratio 2021 -14,2x
Yield 2021 -
Capitalization 2 331 M 2 331 M -
EV / Sales 2021 204x
EV / Sales 2022 67,4x
Nbr of Employees 91
Free-Float 90,9%
Chart ROCKET PHARMACEUTICALS, INC.
Duration : Period :
Rocket Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCKET PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 36,77 $
Average target price 70,70 $
Spread / Average Target 92,3%
EPS Revisions
Managers and Directors
Gaurav Shah President, Chief Executive Officer & Director
Carlos Garcia-Parada Chief Financial Officer
Roderick T. Wong Chairman
Jonathan David Schwartz Chief Medical Officer & SVP-Clinical Development
Kinnari Patel Chief Operating Officer & EVP-Development
Sector and Competitors
1st jan.Capi. (M$)
ROCKET PHARMACEUTICALS, INC.-34.68%2 271
GILEAD SCIENCES, INC.17.22%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.36.10%59 516
REGENERON PHARMACEUTICALS18.94%59 505
VERTEX PHARMACEUTICALS-14.71%52 296